Skip to content
  • Friday, 14 August 2026
  • 10:21 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Laboratory Automation & Robotics

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

Lana Keisha Jul 25, 2026 0

A new paradigm in therapeutic development is emerging as Remepy, a pioneering startup, successfully completed a Phase IIa clinical trial…

Read More
Laboratory Automation & Robotics

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

Lana Keisha Jul 10, 2026 0

A new era in therapeutic innovation is dawning, marked by the successful Phase IIa clinical trial results for Hybridopa, an…

Read More
Laboratory Automation & Robotics

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

Lana Keisha Jun 29, 2026 0

In a significant advancement for integrated medicine, Remepy, a pioneering startup, has announced successful Phase IIa clinical trial results for…

Read More
Laboratory Automation & Robotics

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s.

Lana Keisha Jun 22, 2026 0

A significant stride in the realm of integrated medicine has been reported by Remepy, a pioneering startup, as its innovative…

Read More
Laboratory Automation & Robotics

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

Lana Keisha Jun 15, 2026 0

In a significant advancement for integrated medicine, Remepy, a pioneering startup, has announced successful Phase IIa clinical trial results for…

Read More
Laboratory Automation & Robotics

How Immuto Scientific pairs AI and mass spec for a step change in protein structure throughput

Lana Keisha Jun 1, 2026 0

Immuto Scientific, a trailblazing company co-founded in 2018 by CEO Faraz A. Choudhury, Ph.D., and CTO Daniel Benjamin, Ph.D., both…

Read More
Laboratory Automation & Robotics

How Immuto Scientific Pairs AI and Mass Spec for a Step Change in Protein Structure Throughput

Lana Keisha May 24, 2026 0

Immuto Scientific, a pioneering biotechnology firm co-founded in 2018 by electrical engineers Faraz A. Choudhury, Ph.D. (CEO), and Daniel Benjamin,…

Read More
Laboratory Automation & Robotics

Immuto Scientific Pairs AI and Mass Spectrometry for a Step Change in Protein Structure Throughput

Lana Keisha May 15, 2026 0

Immuto Scientific, a trailblazing company co-founded in 2018 by electrical engineers Faraz A. Choudhury, Ph.D. (CEO) and Daniel Benjamin, Ph.D.…

Read More
Laboratory Automation & Robotics

Immuto Scientific Pairs AI and Mass Spectrometry for a Step Change in Protein Structure Throughput

Lana Keisha May 8, 2026 0

In a significant development poised to accelerate drug discovery, Immuto Scientific, a biotech firm co-founded in 2018 by CEO Faraz…

Read More
Laboratory Automation & Robotics

Immuto Scientific Pairs AI and Mass Spectrometry for a Step Change in Protein Structure Throughput

Lana Keisha Apr 23, 2026 0

Immuto Scientific, a pioneering company co-founded in 2018 by electrical engineers Dr. Faraz A. Choudhury (CEO) and Dr. Daniel Benjamin…

Read More
Sydney Researchers Recreate the Building Blocks of Life by Synthesizing Cosmic Dust in Laboratory ConditionsGilead Sciences Pledges Over 400,000 Doses of AmBisome to Combat Visceral Leishmaniasis, Extending Vital Global Health PartnershipLudwig Cancer Research Study Reveals Novel Combination Therapy to Overcome Differentiation Blockade in Acute Myelogenous LeukemiaNYC Health + Hospitals CEO Signals Willingness to Replace Radiologists with AI
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ